On STAT's podcast, hear about what happened with AbbVie's schizophrenia drug, Amgen's obesity drug and what might happen at ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a ...

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

On Monday, Amgen Inc (AMGN) stock saw a decline, ending the day at $316.91 which represents a decrease of $-2.31 or -0.72% from the prior close of $319.22. The stock opened at $320.58 and touched a ...

Shares of Amgen Inc. AMGN inched 0.06% higher to $317.17 Monday, on what proved to be an all-around positive trading session ...

Amgen Inc's robust product portfolio and pipeline fortify its market position. Strategic acquisitions like Horizon Therapeutics enhance Amgen's therapeutic reach. Patent litigations and market ...

My name is Julianne, and I will be your conference facilitator today for Amgen's Third Quarter 2024 ... launches in multiple markets, including Canada, which launched earlier this year.

The company's stock slumped 7% on Tuesday after analysts at Cantor Fitzgerald said their review of early-stage data on ...